← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Closed-loop tACS targeting EC-II SST interneurons to block t (SST) — 1.00 Metabolic Reprogramming to Reverse Senescence (SIRT1,PGC1A,NAMPT) — 1.00 Closed-loop transcranial focused ultrasound to restore hippo (PVALB) — 1.00 Closed-loop transcranial focused ultrasound with 40Hz gamma (PVALB) — 1.00 Closed-loop focused ultrasound targeting EC-II SST interneur (SST) — 1.00 Beta-frequency entrainment therapy targeting PV interneuron- (SST) — 0.99 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen (TREM2) — 0.99 Closed-loop tACS targeting EC-II PV interneurons to suppress (PVALB) — 0.99 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 (BDNF) — 0.99 Closed-loop tACS targeting EC-II parvalbumin interneurons to (PVALB) — 0.98 SASP Modulation Rather Than Cell Elimination (NFKB1,IL1B,BDNF) — 0.98 LRP1-Dependent Tau Uptake Disruption (LRP1) — 0.98 Hypothesis 7: SST-SST1R/Gamma Entrainment-Enhanced Astrocyte (SST, SSTR1, SSTR2) — 0.97 TREM2-Dependent Microglial Senescence Transition (TREM2) — 0.95 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.95 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.94 PLCG2 Allosteric Modulation as a Precision Therapeutic for T (PLCG2) — 0.94 Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 (CSF p-tau217 (biomarker), lncRNA-0021, hUC-MSC exosomes) — 0.94 Dual-Receptor Antibody Shuttling (%s) — 0.94 SASP-Driven Microglial Metabolic Reprogramming in Synaptic P (HK2/PFKFB3) — 0.93 Multi-Biomarker Composite Index Surpassing Amyloid PET for T (COMPOSITE_BIOMARKER) — 0.93 Closed-loop transcranial alternating current stimulation to (SST) — 0.93 Closed-loop focused ultrasound targeting CA1 PV interneurons (PVALB) — 0.93 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.92 Autophagy-Senescence Axis Therapeutic Window (ATG7,BCL2,BCL2L1) — 0.92 HK2-Dependent Metabolic Checkpoint as the Gatekeeper of DAM (HK2) — 0.92 Palmitoylethanolamide-Based Endocannabinoid Therapy (PPARA) — 0.92 Closed-loop tACS targeting entorhinal cortex layer II SST in (SST) — 0.92 TREM2-mediated microglial tau clearance enhancement (TREM2) — 0.92 Chromatin Remodeling-Mediated Nutrient Sensing Restoration (SMARCA4) — 0.91
Add
|
× Age-Accelerated miR-155 U × IL-6 Trans-Signaling Bloc
miR-155 · neuroinflammation · -
Composite 0.610
Price $0.61
Evidence For 0
Evidence Against 0
Aging induces progressive miR-155 upregulation in substantia nigra microglia, suppressing SOCS1 and increasing NF-κB signaling. This primed state causes exaggerated inflammatory responses to alpha-synuclein fibrils, resulting in excessive TNF-alpha and IL-1beta release that damages dopaminergic neurons. Addresses understudied age-region intersection with testable miRNA-based intervention.
IL6R, IL6 · neuroinflammation · mechanistic
Composite 0.806
Price $0.74
Evidence For 0
Evidence Against 0
In the established paradigm, microglia are primary drivers of neuroinflammation. However, oligodendrocyte-derived IL-6 may prime microglia through IL-6 trans-signaling (IL-6/sIL-6R/gp130), creating a self-reinforcing inflammatory loop. Blocking soluble IL-6 receptor (sIL-6R) specifically at the oligodendrocyte-microglia interface would interrupt this amplification circuit without globally suppressing IL-6, preserving its neuroprotective functions. This extends the SASP-complement cascade concept
Verdict Summary 1/10
dimensions won
Age-Accelerated miR-155 Upregulation Pri
9/10
dimensions won
IL-6 Trans-Signaling Blockade at the Oli
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Age-Accelerated miR-155 Upregu IL-6 Trans-Signaling Blockade Mechanistic 0.640 0.820 Evidence 0.680 0.780 Novelty 0.700 0.650 Feasibility 0.550 0.720 Impact 0.650 0.800 Druggability 0.500 0.850 Safety 0.400 0.580 Competition 0.700 0.750 Data 0.600 0.820 Reproducible 0.620 0.780
Evidence Age-Accelerated miR-155 Upregulation Primes Nigral Microglia No evidence citations yet
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl No evidence citations yet
Debate Excerpts Age-Accelerated miR-155 Upregulation Primes Nigral 4 rounds · quality: 0.73
Theorist # Therapeutic Hypotheses: Microglial Heterogeneity and Disease Susceptibility
---
## Hypothesis 1: Region-Specific TREM2-Dependent Microglial Metabolism Determines Alzheimer's Disease Vulnerability
...
Skeptic # Critical Evaluation of Microglial Heterogeneity Hypotheses
## Hypothesis 1: TREM2-Dependent Regional Metabolism in AD
### Weak Links
1. **Regional specificity is assumed, not demonstrated**: The c...
Domain Expert # Feasibility Assessment: Microglial Heterogeneity Hypotheses
## Preliminary Filtering
Based on the Skeptic's revised confidence scores and mechanistic plausibility, I will assess hypotheses with re...
Synthesizer {
"ranked_hypotheses": [
{
"title": "Regional TREM2-Dependent Lipid Metabolism Determines Cortical Vulnerability in Alzheimer's Disease",
"description": "TREM2 R47H variants impair m...
IL-6 Trans-Signaling Blockade at the Oligodendrocy 4 rounds · quality: 0.79
Theorist
# Mechanistic Hypotheses: Oligodendrocyte-Driven Neuroinflammation in PD
---
## Hypothesis 1: PSAP Cleavage Pattern Determines Pro-inflammatory vs. Protective Function
**Title:** Altered Prosapos...
Skeptic
# Critical Evaluation: Hypothesis 1 — PSAP Cleavage Pattern
## Summary of Hypothesis
Dysregulated PSAP cleavage (via elevated cathepsins/MMPs) generates pathogenic saposin fragments that over-activ...
Domain Expert
# Domain Expert Response: PD Translational Assessment
## Preliminary Note: AD vs. PD Context
I notice the query references an "Alzheimer's clinical landscape," but the research question, source pa...
Synthesizer
{
"ranked_hypotheses": [
{
"rank": 1,
"title": "Altered PSAP Cleavage Generates Pro-inflammatory Fragments in Oligodendrocytes",
"mechanism": "Disease-associated proteases (c...
Price History Overlay
Knowledge Graph Comparison
Age-Accelerated miR-155 Upregulation Pri
1 edges
Top Node Types debate_session 1
IL-6 Trans-Signaling Blockade at the Oli
2 edges
Top Relations promoted: IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microglia Interface 1
promoted: PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocytes 1